Stock Market Today: S&P 500 Closes At Record After GDP Surprise

Group 1: Novo Nordisk and GLP-1 Pills - Novo Nordisk's shares increased by nearly 10% following FDA approval of the oral version of Wegovy, a GLP-1 weight loss drug, with a starting price of $149/month available in early January [2][3] - The approval gives Novo Nordisk a competitive edge over Eli Lilly, which is developing its own oral GLP-1 medication, orforglipron, expected to launch next year [3] Group 2: Warner Bros. Discovery and Paramount Skydance - Warner Bros. Discovery is in a bidding war with Netflix for its HBO parent company, indicating a significant shift in the entertainment landscape [4] - Paramount Skydance, despite losing the bidding war, is making personal guarantees from Oracle CEO Larry Ellison, who is willing to invest over $40 billion to reassure investors [5] - If Netflix fails to secure regulatory approval, Paramount Skydance could be positioned to acquire Warner Bros. Discovery, making the situation critical to monitor [6]